Rapport Therapeutics, Inc. Common Stock
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Rapport Therapeutics, Inc. Common Stock's balance sheet done over the years? Its assets were worth $155,423,000 last year. 9% of Rapport Therapeutics, Inc. Common Stock’s total assets is currently financed by debt. Its liabilities reached the amount of $14,479,000.
Debt to Assets
| 2023 | 155423000 | 14.47M | 9.32% |
|---|
RAPP Balance Sheet (2023 – 2023)
| 2023 | |
|---|---|
Assets | |
Current assets: | |
Cash and cash equivalents | 70.16M |
Short term investments | 77.30M |
Net receivables | 0 |
Inventory | 0 |
Other current assets | 3.30M |
Total current assets | 150.87M |
Non-current assets: | |
Property, Plant and Equipment | 4M |
Goodwill | 0 |
Intangible assets | 0 |
Long term investments | 0 |
Other non-current assets | 550.99K |
Total non-current assets | 4.55M |
Total assets | 155.42M |
Liabilities | |
| Current liabilities: | |
Accounts payable | |
Deferred revenue | 0 |
Short term debt | 670K |
Total current liabilities | 8.80M |
| Non-current liabilities: | |
Long term debt | 1.47M |
Deferred tax | 0 |
Other non-current liabilities | 4.19M |
Total non-current liabilities | 5.67M |
Total liabilities | 14.47M |